Seeking Alpha

KarinCA's  Instablog

Send Message
I'm an independent writer/trader/investor whose primary interests are in the stem cell and biotech arena. My secondary interest is in oil/energy speculation. I do venture elsewhere at times. There’s an option to follow me at the top of any article I write. Click it and you’ll also see an option... More
  • CJEU Court Agrees With ISCO And UK Court. Opens Way For EU Patents To Be Filed. 0 comments
    Jul 17, 2014 10:29 AM | about stocks: ISCO

    CJEU Court Agrees with ISCO and UK Court. Finds Parthenote?s not Human Embryos. This opens the way for EU patents to be filed.

    The Advocate General delivered his opinion this morning, agreeing with the UK Court and ISCO that parthenotes, because they cannot become humans, should not be considered part of the definition of a human embryo.;jsessionid=9ea7d0f130deb01dbf66d01d4f3d8605f6d772354805.e34KaxiLc3eQc40LaxqMbN4OaNyTe0?text=&docid=155123&pageIndex=0&doclang=en&mode=lst&dir=&occ=first&part=1&cid=338666
    "V - Conclusion

    80. In the light of the foregoing, I suggest that the Court should answer the question referred by the High Court of Justice, Chancery Division (Patents Court) as follows:

    Unfertilised human ova whose division and further development have been stimulated by parthenogenesis are not included in the term 'human embryos' in Article 6(2)(c) of Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions as long as they are not capable of developing into a human being and have not been genetically manipulated to acquire such a capacity."

    Disclosure: The author is long ISCO.

Back To KarinCA's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $CTIX submitted an application to the NASDAQ Exchange for uplisting... ...
    Feb 8, 2015
    Jan 20, 2015
  • $CTIX Reports Spleen Lesion 'Disappears' in Patient With Metastatic Stage 4 Ovarian Cancer in Clinical Trial of Anti-Cancer Drug Kevetrin
    Jan 20, 2015
More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.